Drug Type Small molecule drug |
Synonyms Picovir, Pleconaril (USAN/INN) + [5] |
Target- |
Mechanism Virus replication inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC18H18F3N3O3 |
InChIKeyKQOXLKOJHVFTRN-UHFFFAOYSA-N |
CAS Registry153168-05-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05528 | Pleconaril |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Systemic Inflammatory Response Syndrome | NDA/BLA | CA | 27 Jun 2001 | |
Enterovirus Infections | Phase 3 | CA | 27 Jun 2001 | |
Systemic Inflammatory Response Syndrome | Phase 3 | US | 27 Jun 2001 | |
Picornaviridae Infections | Phase 1 | - | - | |
Picornaviridae Infections | Phase 1 | - | - | |
Enterovirus Infections | Preclinical | US | 27 Jun 2001 | |
Picornaviridae Infections | Preclinical | - | - | |
Picornaviridae Infections | Preclinical | - | - | |
Picornaviridae Infections | Preclinical | - | - | |
Common Cold | Discovery | - | 01 Aug 2006 |
Phase 2 | 311 | (Pleconaril) | ummbyjhiyl(yhhaxvwydg) = phudsxphji rnhgoqvtzh (qxacfdyfmf, oamjdhczar - woumljnurn) View more | - | 31 Oct 2013 | ||
Placebo to Pleconaril (Placebo) | ummbyjhiyl(yhhaxvwydg) = nsgmvcreiu rnhgoqvtzh (qxacfdyfmf, ssppvcugxi - siwhofcrui) View more |